Tag: discontinuation

Alicia Martin is an Australian community pharmacist and the creator of an ingenious mobile app, TaperMate, which aims to help people with hyperbolic drug tapering and prescribed drug withdrawal.

Together, we can create a new way to support patients tapering psychiatric medications and the medically orphaned will finally feel welcomed.

Past research has framed symptom increases during tapering and discontinuation of psychotropic drugs as a relapse of an underlying “illness.” A new preprint article...

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported biological beliefs about mental "illness," and research linking...

Researchers found that for many doctors, renewing antidepressant prescriptions feels safer and faster than helping people taper, and that most current interventions fail to address the pressures driving that choice.

A new study in Health Expectations led by Trinity College Dublin researchers finds that people withdrawing from psychiatric medications often endure severe symptoms, limited clinical support, and widespread uncertainty about how to taper safely.

I have been on Cymbalta for 17 years now and am gutted that my five-year taper did not free me of the drug.

Mental health nursing has a key role to play in helping people discontinue the drugs, writes Timothy Wand.

Drug-first treatment overlooks the underlying circumstances that contributed to the development of mental health issues in the first place.

A new study published in Psychology and Psychotherapy: Theory, Research and Practice finds that psychiatrists and other doctors are the most unhelpful factor for...

A response to a seriously flawed review.

For thirty years, Dr. Giovanni Fava has sounded the alarm on the long-term effects of antidepressants and the risks of withdrawal, pushing back against pharmaceutical narratives.

The medications are there to disconnect us from our divine, creative Self, but the human being is remarkable and incredibly resilient.

New research highlights the ethical responsibilities of clinicians in supporting patients who choose to reduce or discontinue antipsychotic medication.

Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

New research finds the negative drug effects most commonly associated with initiating antidepressant discontinuation are anxiety, suicidal thoughts, vomiting, and rashes.

New study reveals: 2 in 3 people need more than the current antidepressant benefits to consider them worthwhile.

Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.

In online communities, patients learn their strange symptoms may be due to the medications they are taking, and are offered solutions that provide hope.

The problems related to the use of antidepressants cannot be solved by an oversimplified psychiatry brainwashed by the pharmaceutical industry.

Supportive patient-practitioner relationships are crucial to the successful discontinuation of psychiatric medication.

Researchers argue that common study methods for psychiatric drugs may inadvertently minimize withdrawal effects and inflate drug efficacy.

A meta-analysis published last month showed that psychotherapy has an enduring effect on depression—in contrast to depression pills.

Leading researchers point out that a new antidepressant study in NEJM failed to account for withdrawal symptoms, casting doubt on the results.

New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.